Clinical translation of the GRPR antagonist [99mTc]Tc-maSSS-PEG2-RM26 for targeting prostate tumors

被引：0
|
作者：
Orlova, Anna [1 ]
Abouzayed, Ayman [1 ]
Rinne, Sara [1 ]
Lushnikova, Nadezhda [2 ]
Usynin, Evgeny [2 ]
Doroshenko, A. [2 ]
Borin, Jesper [3 ]
Sorensen, Jens [1 ]
Tolmachev, Vladimir [1 ]
Chernov, Vladimir [2 ]
Rybina, Anastasia [2 ]
机构：
[1] Uppsala Univ, Uppsala, Sweden
[2] Russian Acad Sci, Tomsk Natl Res Med Ctr, Moscow, Russia
[3] KTH Royal Inst Technol, Stockholm, Sweden
来源：
NUCLEAR MEDICINE AND BIOLOGY | 2022年 / 114卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
P-54
引用
收藏
页码：S58 / S58
页数：1
相关论文
共 49 条
  • [31] Initial Experience of Clinical Use of [99mTc]Tc-PSMA-T4 in Patients with Prostate Cancer. A Pilot Study
    Cwikla, Jaroslaw B.
    Roslan, Marek
    Skoneczna, Iwona
    Kempinska-Wrobel, Monika
    Maurin, Michal
    Rogowski, Wojciech
    Janota, Barbara
    Szarowicz, Anna
    Garnuszek, Piotr
    PHARMACEUTICALS, 2021, 14 (11)
  • [32] HER2-specific Affibody Molecule [99mTc]Tc-ZHER2:41071: phase I clinical trial
    Tolmachev, Vladimir
    Bragina, Olga
    Chernov, Vladimir
    Larkina, Maria
    Rybina, Anastasiya
    Zelchan, Roman
    Oroujeni, Maryam
    Loftenius, Annika
    Orlova, Anna
    Sorensen, Jens
    Frejd, Fredrik
    NUCLEAR MEDICINE AND BIOLOGY, 2023, 126 : S197 - S198
  • [33] HER2-specific Affibody Molecule [99mTc]Tc-ZHER2:41071: phase I clinical trial
    Tolmachev, V.
    Bragina, O.
    Larkina, M.
    Rybina, A.
    Zelchan, R.
    Oroujeni, M.
    Loftenius, A.
    Orlova, A.
    Sorensen, J.
    Frejd, F.
    Chernov, V.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S264 - S264
  • [34] Preclinical Evaluation of a Novel High-Affinity Radioligand [99mTc]Tc-BQ0413 Targeting Prostate-Specific Membrane Antigen (PSMA)
    Bezverkhniaia, Ekaterina
    Kanellopoulos, Panagiotis
    Abouzayed, Ayman
    Larkina, Mariia
    Oroujeni, Maryam
    Vorobyeva, Anzhelika
    Rosenstrom, Ulrika
    Tolmachev, Vladimir
    Orlova, Anna
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (24)
  • [35] Gallium-66 PET: Production and characterization of 66Ga-NOTA-PEG2-RM26 for PET-imaging of GRPR expression in prostate cancer
    Rinne, S.
    Abouzayed, A.
    Gagnon, K.
    Tolmachev, V.
    Orlova, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S371 - S372
  • [36] Comparison of SSTR2 agonist and antagonist peptides incorporating a novel 99mTc-chelator for targeting neuroendocrine tumors
    Marquis, John
    Maresca, Kevin
    Lu, Genliang
    Hillier, Shawn
    Zimmerman, Craig
    Reubi, Jean Claude
    Maecke, Helmut
    Eckelman, William
    Joyal, John
    Babich, John
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [37] Clinical Translation of Gastrin Releasing Peptide Receptor Antagonist 68Ga-NOTA-RM26 in Healthy Volunteers and Prostate Cancer Patients
    Zhang, Jingjing
    Lang, Lixin
    Fan, Xinrong
    Li, Fang
    Niu, Gang
    Zhu, Zhaohui
    Chen, Xiaoyuan
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [38] 66Ga-PET-imaging of GRPR-expression in prostate cancer: production and characterization of [66Ga]Ga-NOTA-PEG2-RM26
    Sara S. Rinne
    Ayman Abouzayed
    Katherine Gagnon
    Vladimir Tolmachev
    Anna Orlova
    Scientific Reports, 11
  • [39] 66Ga-PET-imaging of GRPR-expression in prostate cancer: production and characterization of [66Ga]Ga-NOTA-PEG2-RM26
    Rinne, Sara S.
    Abouzayed, Ayman
    Gagnon, Katherine
    Tolmachev, Vladimir
    Orlova, Anna
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [40] The effect of macrocyclic chelators on the targeting properties of the 68Ga-labeled gastrin releasing peptide receptor antagonist PEG2-RM26
    Varasteh, Zohreh
    Mitran, Bogdan
    Rosenstrom, Ulrika
    Velikyan, Irina
    Rosestedt, Maria
    Lindeberg, Gunnar
    Sorensen, Jens
    Larhed, Mats
    Tolmachev, Vladimir
    Orlova, Anna
    NUCLEAR MEDICINE AND BIOLOGY, 2015, 42 (05) : 446 - 454
12345